|
SLC41A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.43829956225738E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.164510E-04 |
| Normal-vs-Stage2 |
5.839500E-03 |
| Normal-vs-Stage3 |
4.04769999999832E-05 |
| Normal-vs-Stage4 |
5.214400E-02 |
| Stage1-vs-Stage2 |
4.963000E-01 |
| Stage1-vs-Stage3 |
2.458100E-03 |
| Stage1-vs-Stage4 |
1.791840E-01 |
| Stage2-vs-Stage3 |
9.839800E-02 |
| Stage2-vs-Stage4 |
4.502600E-01 |
| Stage3-vs-Stage4 |
6.079600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.23679999364646E-09 |
| Normal-vs-AfricanAmerican |
4.007400E-04 |
| Normal-vs-Asian |
9.209800E-02 |
| Caucasian-vs-AfricanAmerican |
6.840000E-01 |
| Caucasian-vs-Asian |
4.535400E-01 |
| AfricanAmerican-vs-Asian |
3.461000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.23780000027551E-07 |
| Normal-vs-Female |
2.21660000021551E-07 |
| Male-vs-Female |
2.914000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.942700E-03 |
| Normal-vs-Extreme_Weight |
4.484300E-03 |
| Normal-vs-Obese |
3.58940000000363E-05 |
| Normal-vs-Extreme_Obese |
3.284400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.351420E-01 |
| Normal_Weight-vs-Obese |
3.939800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.321800E-01 |
| Extreme_Weight-vs-Obese |
5.823700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.900000E-01 |
| Obese-vs-Extreme_Obese |
1.626370E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.043400E-04 |
| Normal-vs-Age(41-60Yrs) |
6.93070001389628E-09 |
| Normal-vs-Age(61-80Yrs) |
2.775200E-04 |
| Normal-vs-Age(81-100Yrs) |
3.441800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.057400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.321500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.286400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.516370E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.944800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.737800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.07989999999603E-05 |
| Normal-VS-Type2 PRCC |
1.04700000003177E-06 |
| Normal-VS-KIRP CIMP |
4.539200E-03 |
| Normal-VS-Unclassified PRCC |
1.413370E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.543300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.170900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.064100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.881400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.918000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.904200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.003950E-04 |
| Normal-vs-N1 |
1.407540E-04 |
| Normal-vs-N2 |
1.735560E-01 |
| N0-vs-N1 |
2.433000E-01 |
| N0-vs-N2 |
6.685200E-01 |
| N1-vs-N2 |
9.000600E-01 |
|
|
